Akash Bajaj, MD
Interventional Pain Medicine · Marina del Rey, CANPI 1689752164
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 406 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Boston Scientific at 28.4% of the total. Reporting peaked in 2019 at $2,863 and has fallen 64.6% since, to $1,013 in 2025.
Across 406 payments — averaging $33.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$3K
- Abbott$3K
- Vertiflex, Inc.$1K
- Relievant Medsystems, Inc.$488
- Nevro Corp.$438
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$8006%
- Travel & lodging$1581%
- Food & beverage$12,60293%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 150 | $3,850 |
| Medtronic(2 entities) | 78 | $3,165 |
| Abbott | 75 | $2,555 |
| Vertiflex, Inc. | 20 | $1,051 |
| Relievant Medsystems, Inc. | 8 | $488 |
| Nevro Corp. | 10 | $438 |
| Merz Pharmaceuticals, LLC | 10 | $365 |
| Saluda Medical Americas, Inc. | 4 | $256 |
| SPR Therapeutics, Inc | 6 | $189 |
| Merz North America, Inc. | 5 | $188 |
| Nalu Medical, Inc. | 1 | $113 |
| AbbVie | 7 | $109 |
| Spinesmith Holdings, LLC | 1 | $80 |
| Stratus Medical, LLC | 2 | $67 |
| Curonix LLC | 2 | $64 |
| Lilly USA, LLC | 3 | $63 |
| Painteq LLC | 3 | $63 |
| Globus Medical | 2 | $54 |
| Pacira Pharmaceuticals Incorporated | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Stimwave Technologies Incorporated | 2 | $43 |
| Si-bone, Inc. | 1 | $35 |
| Vertos Medical, Inc. | 1 | $33 |
| Zimmer Biomet | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Vertex | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Spinal Simplicity, LLC | 1 | $20 |
| Pfizer | 1 | $20 |
| Terumo BCT, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Amgen | 1 | $14 |
| Medline Industries LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$972
- VECTRIS$800
- Superion ISS$579
- INTELLIS ADAPTIVESTIM$450
- GENERAL PAIN MANAGEMENT$361
- Intracept$308
- Senza Spinal Cord Stimulation System$161
- ADAPTIVESTIM$149
- SUPERION$121
- PlasmaBlade$119
- Evoke$117
- Nalu Neurostimulation System$113
- TARGETSTIM$102
How this compares
$13,560 in reported general payments places this provider in the 80th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 29 | $445 |
| Pregabalin | 37 | $173 |
| Tizanidine Hcl | 43 | $133 |
| Methylprednisolone | 19 | $92 |
| Ibuprofen | 14 | $66 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $27 |
| Tramadol Hcl | 14 | $15 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Marina del Rey
- Leia RispoliMarina del Rey$35K
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.